Corpus Intelligence IC Memo — WAMEGO HOSPITAL ASSOCIATION 2026-04-26 11:18 UTC
IC Memo — WAMEGO HOSPITAL ASSOCIATION
Investment Committee Memorandum | KS | 18 beds | Grade D | EBITDA uplift $970K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

WAMEGO HOSPITAL ASSOCIATION

CCN 171337 | POTTAWATOMIE, KS | 18 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

WAMEGO HOSPITAL ASSOCIATION is a 18-bed community hospital in POTTAWATOMIE, KS with $13.1M in net patient revenue and a -5.0% operating margin. The hospital serves a payer mix of 72.7% Medicare, 0.0% Medicaid, and 27.3% commercial.

Thesis: Turnaround. Our ML models identify $970K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.0% to 2.4% (+738bps).

Net Revenue HCRIS$13.1M
Current EBITDA COMPUTED$-652K
Operating Margin COMPUTED-5.0%
Occupancy HCRIS17.8%
Revenue / Bed COMPUTED$730K
Net-to-Gross HCRIS42.7%
Distress Probability MLnan%

2. Market Context & Competitive Position

152
KS Hospitals
-17.7%
State Median Margin
104
Comparable Hospitals

KS has 152 Medicare-certified hospitals with a median operating margin of -17.7%. The target's margin of -5.0% places it above the state median. Among 104 size-comparable peers (9-36 beds), the median margin is -20.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (9-36), prioritizing same-state peers. 104 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WAMEGO HOSPITAL ASSOCIATION (Target)KS18$13.1M-5.0%
KANSAS CITY ORTHOPAEDIC INSTITKS17$86.3M21.1%
NEWMAN REGIONAL HEALTHKS23$73.9M-15.6%
KANSAS SPINE & SPECIALTY HOSPIKS35$69.6M19.1%
KANSAS SURGERY & RECOVERY CENTKS30$62.8M20.0%
UKHS GREAT BEND CAMPUSKS29$53.8M-22.8%
NEOSHO MEMORIAL REGIONAL MED CKS21$53.8M-13.0%
ADVENTHEALTH OTTAWAKS36$53.4M-5.2%
ATCHISON HOSPITAL ASSOCIATIONKS25$50.3M-11.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $970K (738bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$276K+210bp18mo
Cost to Collect4.5%2.5%$263K+200bp12mo
Denial Rate Reduction12.0%6.5%$261K+199bp12mo
A/R Days Reduction5200.0%3800.0%$160K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+7bp6mo

5. EBITDA Bridge

Net Collection Rate
$276K
Cost to Collect
$263K
Denial Rate Reduction
$261K
A/R Days Reduction
$160K
Clean Claim Rate
$10K
Total EBITDA Uplift$970K
Current EBITDA$-652K
+ RCM Uplift+$970K
Pro Forma EBITDA$318K
Current Margin-5.0%
Pro Forma Margin2.4%
WC Released (1x)$504K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.0M$5.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.0M$5.6M0.00x-100.0%
Bull Case9.0x11.0x$-902K$8.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-902K$9.0M0.00x-100.0%
Bear Case11.0x10.0x$-1.1M$875K0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.1M$604K0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 72.7% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 17.8%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 104 hospitals with 9-36 beds
  • Same-state prioritization (n=106)
  • Comp margins: P25=-31.3% / P50=-20.7% / P75=-12.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.